PAVmed Inc. (PAVM)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, PAVmed Inc. reported revenue of $71.0K, down 97.6% from the prior year. The company was profitable, with a net margin of 564.8%. It held $38.81M in total assets against $16.51M in total liabilities.
Key ratios (FY2025)
-30712.7%
Operating margin
564.8%
Net margin
1.2%
Return on equity
-97.6%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.0K | $3.00M | $2.45M | $377.0K | $500.0K | — | — | — | — | — |
| Cost of Revenue | $218.0K | $4.84M | $6.42M | $3.61M | $585.0K | — | — | — | — | — |
| Gross Profit | — | — | — | — | -$85.0K | — | — | — | — | — |
| Operating Income | -$21.81M | -$44.49M | -$68.80M | -$91.09M | -$54.39M | -$23.35M | -$14.29M | -$10.56M | -$8.03M | -$5.65M |
| Net Income | $401.0K | $39.79M | -$64.17M | -$88.98M | -$50.35M | -$34.28M | -$16.46M | -$17.97M | -$9.52M | -$5.65M |
| EPS (Diluted) | $-5.63 | $99.15 | $-9.16 | $-15.03 | $-0.65 | — | — | — | — | — |
| Total Assets | $38.81M | $30.66M | $33.12M | $53.98M | $86.98M | $19.78M | $7.24M | $8.50M | $1.64M | $870.4K |
| Total Liabilities | $16.51M | $37.69M | $57.14M | $43.05M | $7.56M | $20.25M | $11.88M | $10.97M | $4.49M | $1.19M |
| Shareholders' Equity | $33.97M | -$2.50M | -$53.83M | -$9.68M | $61.67M | $1.90M | -$3.82M | -$2.31M | -$2.85M | -$319.1K |
| Cash & Equivalents | $1.54M | $1.19M | $19.64M | $39.74M | $77.26M | $17.26M | $6.22M | $8.22M | $1.54M | $585.7K |
| Operating Cash Flow | -$5.21M | -$33.55M | -$52.04M | -$70.98M | -$40.59M | -$21.91M | -$13.36M | -$8.79M | -$6.61M | — |
| Capital Expenditures | $31.0K | $55.0K | $242.0K | $1.54M | $1.47M | $55.0K | $27.0K | $26.6K | $5.3K | $21.8K |
| Shares Outstanding | 927.9K | 373.3K | 8.58M | 6.30M | 86.37M | 63.82M | 40.48M | 27.14M | 14.55M | 13.33M |